|Home Page : www.otcjournal.com
Email Questions or Comments To: email@example.com
OTC Journal Members:
All the Tea in China is no longer All the Tea in China. I'm sure you're wondering what the heck I'm talking about.
China is where they invented the stuff, and it's been consumed as an enjoyable beverage with some perceived positive side effects for 5,000 years. In the last 20 years, scientists have started to understand the very powerful healthy side effects Green Tea extract delivers to the body- therefore, while the euphemism"All The Tea in China" used to mean a whole bunch of tea- about all there was in the world, it's no longer the case. Tea- more importantly tea extracts- have spread globally, and all the Tea is no longer In China.
There is more tea consumed globally than any other individual beverage. The only liquid with higher human consumption is water. Only about 2.9 million tons of tea are grown annually around the world. The beverage was discovered about 5,000 years ago by Shan Nong, a Chinese Emperor, in 2737 BC. Like many of the world's great discoveries, it happened by accident. A few leaves fell into his drinking water as it was being boiled, and he is said to have enjoyed the alluring aroma and taste.
Western cultures have only consumed tea for the last 500 years as trade expanded between East and West.
Tea has taken on a whole new persona in the last 10 years as research has proven the therapeutic value of tea has long been underestimated. Tea extracts, through multiple clinical trials, have now been proven to extend life, reduce medical costs, decrease weight, increase metabolism, decrease stress, and increase anti oxidants.
The demand for healthier alternatives is proven out by two outstanding companies in this sector:
Green tea extracts have become a prominent part of the businesses of many of these health product companies. There are six major manufacturers of Green Tea Extract globally, and the stuff sells for anywhere from $80 per kilo to $540 per kilo.
Today's new idea has the most exciting new technology to ever come along in this sector. Plandia Biotechnology (PLPL) has developed an extraction process for Green Tea Extracts that delivers many times the health benefits of the status quo.
Read on McDuff.........
PLPL is a complicated story. However, the way you can make money in the short term is very simple.
Here's the 30,000 ft overview. A couple of pHd scientists spent the last 10 years developing new extraction technology that creates by far the best green tea extract known to man. In several studies it has proven to be far and away the most "Bioavailble" green tea extract. About 2 ounces of their extract provides the same benefit you would expect from a gallon of the other guy's stuff.
In order to begin commercialization using this revolutionary new technology, the company ventured to one of the best places on Planet Earth to grow green tea. It also happens to have a very favorable political climate- money is available from the government.
The tea growing region of South Africa has a 70% unemployment rate and tea plantations have grown fallow since Apartheid. Native South Africans took back their plantations, but they didn't have the skills or resources to operate them.
At the end of January PLPL received a formal commitment from the Land and Agricultural Development Bank of South Africa for a 100 Million Rand debt financing (about $13 million).
The capital will be used to restore 300 hectares of prime green tea farm land in South Africa. This land is absolutely ideal for this crop. Nine months of the year green tea can be grown and harvested every 19 days.
A smaller portion of the funds will be used to restore the tea growth. The larger portion of the funds will be used to build and install PLPL's proprietary Green Tea Extraction technology, which is patented and proven out in many scientific studies.
The loans have not closed as of this time. The Land Bank, which is a quasi government agency in South Africa assigned to task of making loans that will put people to work, has required the company to restructure the loans so they could be divided up equitably amongst the company's subsidiaries. To read the SEC filing that describes the delay on funding and the subsequent completion of the requirements, simply click here.
Since I'm going to be covering this one for the next 6 months, I'm going to leave out a lot of information I'll save for future editions.
I could write volumes on the revolutionary new Green Tea Extract method the company has devised and patented. When seen to fruition, this extract will be far more "Bioavailable" to the human body (meaning the body will absorb a far higher percentage), and be pharmaceutical quality. Lots more on this in future editions.
However, making money in the short term is a very simple matter, and the chart tells us exactly what's likely to happen.
PLPL announced the signed commitment for the capital from the Land Bank at the end of January. As you can see from this chart, the stock traded up to $.60 on the news.
The closing of the financing has been delayed, and the stock is now $.25.
If you invest in this stock today at about $.25 while it's at the very low end of it's trading range, and wait until the company gets the funding closed, the stock is likely to head back to the $.60 level- where it was when the market expected the loan to close in the short term.
Hence- 140% on your money from today's levels if and when it happens.
While no one can use the word "guarantee" with regard to the closing of the loan, I have interviewed CEO Roger Duffield extensively from South Africa, and reviewed last week's SEC filing.
I believe it's highly likely this loan will close, and the company will immediately begin the process of restoring these lands to productivity and assembling the required equipment for their amazing extraction process.
There you have it- $.25 today. Back to $.60 on the news, which could come any day. There's not much technical downside as the stock is trading very close to its lowest historical level.
Once the funds have been secured, we can take a much harder look at the value of Green Tea Extract, and in particular PLPL's proprietary technology that makes for the highest grade and most bioavailable Green Tea Extract in history.
I would suggest accumulating at around $.25 with a short term price target of $.60 and an SSL of $.15.
Take your position, then hold for the news, which will be just the beginning of this story, and the start of a highly profitable saga.Home Page : www.otcjournal.com
Email Questions or Comments To: firstname.lastname@example.org
The OTC Journal Newsletter is an electronic publication committed to providing our readers with useful information on publicly traded companies. The Newsletter contracts with publicly traded companies and receives compensation from them or third parties as payment for publishing information and opinions about the company and the trading market for their securities. Principals of the Newsletter may also purchase or sell securities of the companies in the open market from time to time. The positions, if any, that the Newsletter or its principals presently maintain in the securities of the companies are disclosed here (click here) and should be considered in making an investment decision regarding these companies securities. The Newsletter and its principals reserve the right to acquire additional shares or liquidate some or all of the positions they may hold in the issuer’s securities at any time in the future without further notice. These publications should not be considered to be independent publications concerning the company.
All statements and opinions expressed herein are those of the editors and are subject to change without notice. The Newsletter maintains editorial control over its publications and the companies profiled therein do not have any editorial rights concerning the information published about them. While we believe all sources of information provided by us and contained in our publication to be accurate and reliable, we cannot and do not guarantee the accuracy of information we received from third parties.
We encourage our readers to invest carefully and read the investor information available at the web sites of the Securities and Exchange Commission ("SEC") at http://www.sec.gov and/or the National Association of Securities Dealers ("NASD") at http://www.finra.org. We also recommend that you read the SEC advisory to investors concerning Internet Stock Fraud, which can be found at http://www.sec.gov/consumer/cyberfr.htm. Readers can review all public filings by companies at the SEC's EDGAR page. The NASD has published information on how to invest carefully at its web site.
The information found in this profile is protected by the copyright laws of the United States and may not be copied, or reproduced in any way without the express written consent of the editors of otcjournal.com.